R-tPA

R-tPA or Recombinant tissue plasminogen activator is a thrombolytic drug, one of the pharmaceuticals that promotes thrombolysis. It is produced through recombinant DNA technology, and is used to treat conditions like acute ischemic stroke and myocardial infarction (heart attack).

Mechanism of Action

R-tPA works by catalyzing the conversion of plasminogen to plasmin. Plasmin is an enzyme that breaks down fibrin clots, a type of blood clot. This action can help to restore blood flow in the affected area.

Uses

R-tPA is used in the treatment of acute ischemic stroke and myocardial infarction. It can also be used in cases of massive pulmonary embolism.

Side Effects

The most common side effect of R-tPA is bleeding. Other side effects can include allergic reactions, low blood pressure, and edema.

Contraindications

R-tPA should not be used in patients with active internal bleeding, recent surgery, or a history of stroke within the past three months.

See Also

• Thrombolysis
• Acute ischemic stroke
• Myocardial infarction
• Pulmonary embolism

R-tPA Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski